Our mission is to better understand antibiotic resistance to combat this crisis and improve human health.
Our goals include learning how antibiotic resistance develops, optimizing the way antibiotics are used to preserve their power, and discovering novel therapeutics and vaccines to directly combat antibiotic-resistant pathogens. Solving the crisis of antibiotic resistance requires a multi-faceted approach that crosses traditional boundaries. At the Emory Antibiotic Resistance Center (Emory ARC), clinicians and basic scientists work side-by-side in an environment that combines the essential intellectual and physical resources needed. Working in partnership with government and public and private institutions in the US and worldwide, Emory ARC represents a new and critical component of the fight against antibiotic resistance.
What is Antibiotic Resistance?
Antibiotics kill or inhibit the growth of bacteria. Antibiotic resistance refers to the ability of bacteria to resist one or multiple antibiotics. Unfortunately, rates of antibiotic resistance continue to increase, outpacing the development of new antibiotics. Some bacteria are now resistant to all available antibiotics, rendering infections with these strains essentially untreatable. New research and new approaches are critical to combat this growing crisis.
For additional helpful information, please see the links below: